Based on an IQVIA webinar featuring dementia experts, this insight brief explores how advances in diagnostics, biomarkers, AI, and disease-modifying therapies are transforming Alzheimer’s disease management. The report emphasizes the importance of shifting diagnosis and intervention earlier in the disease continuum, often before symptoms emerge. It highlights the growing role of primary care providers, predictive AI models, blood-based biomarkers, and digital assessments in identifying at-risk individuals. The brief also discusses the need for more sensitive clinical outcome assessments and stresses that healthcare systems must prepare operationally and clinically to support earlier diagnosis, prevention strategies, and personalized interventions as Alzheimer’s care evolves.

Join for free to read